Statements (24)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:anticoagulant
|
| gptkbp:antidote |
gptkb:andexanet_alfa
|
| gptkbp:category |
gptkb:anticoagulant
selective Factor Xa inhibitor |
| gptkbp:contraindication |
active pathological bleeding
|
| gptkbp:example |
gptkb:rivaroxaban
gptkb:apixaban gptkb:betrixaban gptkb:edoxaban gptkb:fondaparinux |
| gptkbp:inhibitedBy |
gptkb:Factor_Xa
|
| gptkbp:mechanismOfAction |
blocks conversion of prothrombin to thrombin
|
| gptkbp:routeOfAdministration |
oral
intravenous |
| gptkbp:sideEffect |
gptkb:anemia
nausea bleeding |
| gptkbp:usedFor |
prevention of stroke in atrial fibrillation
treatment of deep vein thrombosis treatment of pulmonary embolism |
| gptkbp:bfsParent |
gptkb:DB06690
gptkb:DB09145 |
| gptkbp:bfsLayer |
8
|
| https://www.w3.org/2000/01/rdf-schema#label |
Factor Xa inhibitor
|